Osaka, Japan

Osamu Nakaguit

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osamu Nakaguit. Retrieved from https://idiyas.com/inventor/osamu-nakaguit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osamu Nakaguit: Innovator in Pharmaceutical Chemistry

Introduction

Osamu Nakaguit is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.

Latest Patents

One of his key patents is focused on disulfide substituted oxazetidine derivatives. This patent outlines a process for producing a 2-cephem or 3-cephem derivative compound, which is crucial for various pharmaceutical applications. The patent details the chemical structure and the specific radicals involved, showcasing Nakaguit's expertise in organic chemistry.

Career Highlights

Osamu Nakaguit is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development efforts. His work has led to innovative solutions in drug formulation and synthesis.

Collaborations

Throughout his career, Nakaguit has collaborated with esteemed colleagues such as Takashi Kamiya and Yoshihisa Saito. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Osamu Nakaguit's contributions to pharmaceutical chemistry, particularly through his patent on disulfide substituted oxazetidine derivatives, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…